T cells isolated from G-CSF-treated multiple myeloma patients are suitable for the generation of BCMA-directed CAR-T cells-Reference-Cited by-同舟云学术

T cells isolated from G-CSF-treated multiple myeloma patients are suitable for the generation of BCMA-directed CAR-T cells

Published:2022-09 Issue: Volume:26 Page:207-223
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Battram Anthony M.^ORCID,Oliver-Caldés Aina,Suárez-Lledó Maria,Lozano Miquel,Bosch i Crespo Miquel,Martínez-Cibrián Núria,Cid Joan,Moreno David F.,Rodríguez-Lobato Luis Gerardo,Urbano-Ispizua Alvaro,Fernández de Larrea Carlos

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference55 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA. Cancer J. Clin.,2021

2. CAR T and CAR NK cells in multiple myeloma: expanding the targets;Shah;Best Pract. Res. Clin. Haematol.,2020

3. CAR T-cells in multiple myeloma: state of the art and future directions;Rodríguez-Lobato;Front. Oncol.,2020

4. European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma;Bruno;Haematologica,2021

5. FDA approves first BCMA-targeted CAR-T cell therapy;Mullard;Nat. Rev. Drug Discov.,2021

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing cytokines to optimize chimeric antigen receptor-T cell therapy for gastric cancer: Current advances and innovative strategies;Biomedicine & Pharmacotherapy;2024-09

2. Clinical evaluation and determinants of response to HBI0101 (BCMA CART) therapy in relapsed/refractory multiple myeloma;Blood Advances;2024-07-31

3. Granulocyte Colony Stimulating Factor-Mobilized Peripheral Blood Mononuclear Cells: An Alternative Cellular Source for Chimeric Antigen Receptor Therapy;International Journal of Molecular Sciences;2024-05-25

4. Update on the current and future use of CAR‐T to treat multiple myeloma;European Journal of Haematology;2023-12-15

5. Treatment Strategies for Multiple Myeloma Treatment and the Role of High-Throughput Screening for Precision Cancer Therapy;Cell Biology and Translational Medicine, Volume 20;2023